Lorundrostat

Adult Dosing .

Dosage forms:  TAB

Investigational New Drug (IND)

[pending FDA approval]

HTN, adjunct tx

[indication/patient population pending FDA approval]

Info: selectively inhibits aldosterone synthase, decreasing aldosterone levels

Peds Dosing .

Dosage forms:  --

Investigational New Drug (IND)

[pending FDA approval]

Info: not anticipated to be applicable to Peds population

Contraindications / Cautions .

com.epocrates.rxweb.beans.StringCollection@4d7a46a1
• pending FDA approval

Adverse Reactions .

Serious Reactions

com.epocrates.rxweb.beans.StringCollection@1f6a7917
• pending FDA approval

Common Reactions

com.epocrates.rxweb.beans.StringCollection@23e9cf70
• pending FDA approval

Pregnancy/Lactation .

Pregnancy

pending FDA approval

Lactation

pending FDA approval

Pharmacology .

Metabolism: pending FDA approval

Excretion: pending FDA approval

Subclass: Aldosterone Synthase Inhibitors

Mechanism of Action
pending FDA approval

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Mineralys Therapeutics, Inc.

DEA/FDA: IND

Retail Price

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>